We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Image of Anna MacDonald

Anna MacDonald

Science Writer

Contact Us

After obtaining a first-class honours degree in biological sciences from the University of East Anglia, Anna worked as a scientific conference producer before joining Technology Networks. As part of her role, Anna helps to coordinate coverage, working with key opinion leaders from industry and academia to produce content across all communities.

Latest Content
Industry Insight

A New Weapon in the War Against Antibiotic Resistance

We spoke to Bruce Savage, CEO at GFC Diagnostics to learn more about the MicroScreen test.

The Rise of Salivary Diagnostics

An interview with Dr. David Wong, Felix & Mildred Yip Professor and Director of the Center for Oral/Head & Neck Oncology Research at University of California Los Angeles.

The 3 Biggest Challenges of Drug Discovery

The path to discovering new drugs can be long and difficult.

6 Pros and 3 Cons of Coffee (According to Research)

Here we take a look at some of the commonly touted reasons why we should (or shouldn’t) reach for our coffee break brew.

Integrating Electronics with the Human Body

Recipient of this year’s IEEE EMBS Trailblazer Award, Dr. Rogers tells us a little about his career and the work his lab is doing to develop biocompatible electronics such as the Lab on the Skin.

Improving Crystal Quality

Nicknamed the ‘Crystallization Guru’, Professor Naomi Chayen of Imperial College London, tells us a little about her career and the work her lab is doing to help advance the crystallization field.

Developing Techniques for Food Analysis

Prof. Tranchida of the University of Messina tells us a little about his career and the work he is doing to develop innovative GC-MS methods for food analysis.
Industry Insight

Triggering All Arms of Immunity

Maximising the efficacy of a vaccine, whilst keeping side effects to a minimum, is one of the biggest challenges vaccine developers face.
Industry Insight

Next Generation Vaccine Manufacturing

Vaccine manufacturing can be a costly and complex process, often making life-saving vaccines unaffordable for resource poor countries.